Observations on patents and other IP from a dual-licensed practitioner
A few hours ago the House of Representatives passed HR 1249. HR 1249 is disingenuously called the “America Invents Act”; for reasons that have been explicated on other blogs, and…
Anyone who’s ever dealt with the USPTO is well aware that there are often times when the person at the USPTO’s end is wrong, but the most efficient response is…
During a discussion with a colleague following my last post on “overlap” rejections in the ILPTO, it became apparent that a few additional points regarding such “overlap” rejections – in…
35 U.S.C. §101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain…
In the previous post I discussed the issue of amending granted US patents to include new dependent claims. In this post I look at the same question with regard to…
NOTE: This is the first part of a two-part post. This part focuses on US practice; the second part will focus on Israel practice. During ex parte patent practice in…
I’m Dan Feigelson. I’ve been practicing patent law for over 30 years. I’m also opinionated, as you may discover in reading my writings here.